Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Larry E. Kahn"'
Autor:
Larry E. Kahn, Archie Thurston, Po-Chang Chiang, Jason D. Blom, Yurong Lai, Cynthia D. Sommers, Yiding Hu, Julia A. Guzova
Publikováno v:
Journal of Pharmaceutical Sciences. 98:4354-4364
Inhaled corticosteroids (ICSs) are often prescribed as the first line therapy for pulmonary diseases such as asthma. The biggest concern of using steroid therapy is the systemic side effects at high dose. To reduce the side effects, the pharmaceutica
Autor:
Philip R. Streeter, William F. Hood, Tammy L. Thurman, John P. McKearn, Joseph K. Welply, Larry E Kahn, Woulfe Susan L, Nancy I. Minster, Joseph B. Monahan, Lillian E Vickery
Publikováno v:
Experimental Hematology. 29:41-50
Objective The progenipoietins, a class of engineered proteins containing both fetal liver tyrosine kinase-3 and granulocyte colony-stimulating factor receptor agonist activities, were functionally characterized in vitro and in vivo. Materials and Met
Autor:
Olga V. Nemirovskiy, Mihir D. Parikh, Monica B. Norton, Jay M. Wendling, Michael S. Davies, Robert J. Mourey, Lakshman E. Rajagopalan, Toni A. Steiner, Ben S. Zweifel, Hideaki Shimada, Christine M. Kornmeier, Thomas P. Misko, Jaime L. Masferrer, Maria A. Payne, Larry E. Kahn, Stephen A. Kolodziej, Richard F Loeffler, Brenda L. Case
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 333(3)
Rho kinase, is the most widely studied downstream effector of the small Rho GTPase RhoA. Two Rho kinase isoforms have been described and are frequently referred to in the literature as ROCK1 and ROCK2. The RhoA-Rho kinase pathway has been implicated
Autor:
Vicky Walker Holway, Neetu Venkatraman, Janice M. Thompson, Po-Chang Chiang, Sumathy Mathialagan, Larry E. Kahn, Cynthia D. Sommers, Horng-Chih Huang, Randall K. Rader, Debra M. Meyer, Julia A. Guzova, Debra S. Garner, Sheri L. Bonar, Yiding Hu, George Hu, Nandini Kishore, John F. Schindler
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 330(2)
Nuclear factor-kappaB (NF-kappaB) is one of the major families of transcription factors activated during the inflammatory response in asthma and chronic obstructive pulmonary disease. Inhibitory factor-kappaB kinase 2 (IKK-2) has been shown to play a
Autor:
Daniella Mortier, Larry E Kahn, Jonathan L. Heeney, Ralf Wagner, Dean L. Mann, Gerrit Koopman, Ann M. Farese, Woulfe Susan L, Thomas J. MacVittie, Henk Niphuis
Publikováno v:
Vaccine. 23(33)
In order to improve the efficacy of current vaccine candidates against HIV/AIDS, we sought to strengthen the induction of immune responses via simultaneous in vivo mobilization of dendritic cells using a chimeric Flt-3 and G-CSF receptor agonists (Pr
Autor:
Larry E, Kahn, Parul D, Doshi, Kelly L, McGarity, Mingfu, Yu, Christine P, Bono, Wen-Rong, Lie, Anne M, Rankin, Mary L, Smidt, Philip R, Streeter, Barbara K, Klein, Joseph K, Welply, Susan L, Woulfe
Publikováno v:
Medical science monitor : international medical journal of experimental and clinical research. 8(12)
Progenipoietin-4 (ProGP-4) is an E. coli derived chimeric growth factor that activates the human Flt3 and G-CSF receptors. ProGP-4 possesses cross-species activity and treatment of mice with ProGP-4 results in increases in the number of WBC and Class
Autor:
Jean P. Favara, Larry E Kahn, Judith G. Giri, Michiko S Huynh, Minnerly John C, N.R. Staten, John P. McKearn, Parul D Doshi, Ned R. Siegel, Ann L. Abegg, Doreen Villani-Price, John Warren Thomas, Walter G. Smith, Lyle E. Pegg
Publikováno v:
Experimental hematology. 29(10)
Objective The signaling pathways induced by promegapoietin (PMP), a family of chimeric growth factors that activate the human IL-3 and c-Mpl receptors, were investigated. Methods The biological activity of PMP was examined by receptor binding, cell p
Autor:
Glenn Ishioka, Larry E Kahn, John Fikes, Carmen Gianfrani, Alessandro Sette, Robert W. Chesnut, Mingsheng Qin, Woulfe Susan L, Philip R Streeter
Publikováno v:
Vaccine 19 (2001): 3710–3719.
info:cnr-pdr/source/autori:Ishioka GY, Fikes J, Qin M, Gianfrani C, Chesnut RW, Kahn LE, Streeter PR, Woulfe SL, Sette A./titolo:Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function./doi:/rivista:Vaccine/anno:2001/pagina_da:3710/pagina_a:3719/intervallo_pagine:3710–3719/volume:19
info:cnr-pdr/source/autori:Ishioka GY, Fikes J, Qin M, Gianfrani C, Chesnut RW, Kahn LE, Streeter PR, Woulfe SL, Sette A./titolo:Dendritic cells generated in vivo by a chimeric hematopoietic growth factor, progenipoietin-4, demonstrate potent immunological function./doi:/rivista:Vaccine/anno:2001/pagina_da:3710/pagina_a:3719/intervallo_pagine:3710–3719/volume:19
Recently, a dual receptor agonist for human Flt3 and G-CSF receptors, progenipoietin-4 (ProGP-4), was shown to be highly effective in expanding DC in vivo. In this study, we examined the immunological activity of ProGP-4-generated dendritic cell (DC)
Publikováno v:
Journal of hematotherapy. 8(2)
Megakaryocytes (MK) were expanded from purified human CD34+ cells obtained from three sources, bone marrow (BM), mobilized peripheral blood progenitor cells (PB), and umbilical cord (UC) blood. CD34+-selected cells were cultured for 12 days with 10 n
Autor:
Larry E. Kahn, Bonita J. Rup
Publikováno v:
International Archives of Allergy and Immunology. 89:387-393
We have identified a monoclonal antibody specific for rat IgE, 44.7b, which blocks binding of rat IgE to the mast cell-like line RBL. Other monoclonal anti-rat IgE antibodies (MARE1 and B5) did not inhibit IgE binding to these cells. Furthermore, 44.